Pharmacogenetics of ribavirin-induced anemia in hepatitis C, Pharmacogenomics, vol.17, pp.1587-1594, 2016. ,
Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance, Curr. Opin. Virol, vol.8, pp.10-15, 2014. ,
International Committee for Standardization in Haematology: recommended methods for red-cell enzyme analysis, Br. J. Haematol, vol.35, pp.331-340, 1977. ,
Hemoglobin during ribavirin-based HCV therapy is closely related to circulating levels of DHEA, J. Med. Virol, vol.89, issue.6, pp.1033-1039, 2017. ,
DHEA and progesterone have a protective effect on ribavirin-induced hemolysis, J. Hepatol, vol.60, pp.897-898, 2014. ,
Ribavirin monitoring in chronic hepatitis C therapy: anaemia versus efficacy, Antivir. Ther, vol.15, pp.687-695, 2010. ,
Effect of ribavirin on the hepatitis C virus (JFH-1) and its correlation with interferon sensitivity, Antivir. Ther, vol.12, pp.805-813, 2007. ,
A new tool to study ribavirininduced haemolysis, Antivir. Ther, vol.17, pp.1311-1317, 2012. ,
Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage, Hepatology, vol.31, pp.997-1004, 2000. ,
Maleimide as an inhibitor in measurement of erythrocyte glucose-6-phosphate dehydrogenase activity, Clin. Chem, vol.24, pp.885-889, 1978. ,
The role of the equilibrative nucleoside transporter 1 (ENT1) in transport and metabolism of ribavirin by human and wild-type or Ent1-/-mouse erythrocytes, J. Pharmacol. Exp. Ther, vol.329, pp.387-398, 2009. ,
Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection, Liver Int, vol.37, pp.5-18, 2017. ,
On the mechanism of interaction of steroids with human glucose 6-phosphate dehydrogenase, Arch. Biochem. Biophys, vol.318, pp.25-29, 1995. ,
Mechanisms of action of ribavirin against distinct viruses, Rev. Med. Virol, vol.16, pp.37-48, 2006. ,
Novel steroid inhibitors of glucose 6-phosphate dehydrogenase, J. Med. Chem, vol.55, pp.4431-4445, 2012. ,
Morphological transformation and phosphatidylserine exposure in erythrocytes treated with ribavirin, Biol. Pharm. Bull, vol.32, 2009. ,
Erythrocyte ribavirin concentration for assessing hemoglobin reduction in interferon and ribavirin combination therapy, Hepatol. Res, vol.34, pp.23-27, 2006. ,
Oxymatrine provides protection against Coxsackievirus B3-induced myocarditis in BALB/c mice, Antivir. Res, vol.141, pp.133-139, 2017. ,
Ribavirin for chronic hepatitis E virus infection in transplant recipients, N. Engl. J. Med, vol.370, 2014. ,
Ribavirin-induced externalization of phosphatidylserine in erythrocytes is predominantly caused by inhibition of aminophospholipid translocase activity, Eur. J. Pharmacol, vol.693, pp.1-6, 2012. ,
Efficiency and safety of an early dose adjustment of ribavirin in patients infected with hepatitis C underexposed to the drug and treated with peginterferon ribavirin, Ther. Drug Monit, vol.64, pp.684-692, 1990. ,
Inhibition of mammalian glucose-6-phosphate dehydrogenase by steroids, Proc. Natl. Acad. Sci. U. S. A, vol.46, pp.447-452, 1960. ,
Acute effects of oral dehydroepiandrosterone on counterregulatory responses during repeated hypoglycemia in healthy humans, Diabetes, vol.65, pp.3161-3170, 2016. ,
, , 1981.
, Arch. Dermatol. Res, vol.270, pp.49-55
The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women, J. Clin. Endocrinol. Metab, vol.71, pp.696-704, 1990. ,
Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action, Curr. Opin. Virol, vol.1, pp.590-598, 2011. ,
The metabolism of ribavirin in erythrocytes and nucleated cells, Int. J. Biochem, vol.22, pp.379-383, 1990. ,
Basic statistical considerations in virological experiments, J. Virol, vol.79, pp.669-676, 2005. ,
Ribavirin suppresses erythroid differentiation and proliferation in chronic hepatitis C patients, J. Viral Hepat, vol.21, pp.416-423, 2014. ,
Effect of gender and ITPA polymorphisms on ribavirin-induced anemia in chronic hepatitis C patients, J. Hepatol, vol.59, pp.964-971, 2013. ,
Augmented glucose-6-phosphate dehydrogenase activity and normal penetration and metabolism of dehydroepiandrosterone in mononuclear leukocytes in psoriasis, 1986. ,
, Dermatol. Res, vol.278, pp.393-397
Ribavirin restores IFNalpha responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes, Gut, vol.65, pp.672-682, 2016. ,
Regulation of the human-erythrocyte hexosemonophosphate shunt under conditions of oxidative stress. A study using NMR spectroscopy, a kinetic isotope effect, a reconstituted system and computer simulation, Eur. J. Biochem, vol.150, pp.371-386, 1985. ,
Importance of glucose-6-phosphate dehydrogenase activity for cell growth, J. Biol. Chem, vol.273, pp.10609-10617, 1998. ,
Mutagenic effects of ribavirin on hepatitis E virus -viral extinction versus selection of fitness-enhancing mutations, Viruses, vol.8, p.283, 2016. ,
In vitro antiviral activity of dehydroepiandrosterone, 17 synthetic analogs and ERK modulators against herpes simplex virus type 1. Antivir. Res. 95, 37e48, Ann. Hepatol, vol.8, pp.316-324, 2009. ,
Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans, J. Clin. Endocrinol. Metab, vol.71, 1990. ,
Modeling ribavirin-induced anemia in patients with chronic hepatitis C virus, CPT Pharmacometrics Syst. Pharmacol, vol.5, pp.65-73, 2016. ,
, Antiviral Research, vol.146, pp.153-160, 2017.